Vaughan Nelson Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-342,494
| Closed | -$14.9M | – | 213 |
|
|
2021
Q4 | $14.9M | Buy |
342,494
+5,814
| +2% | +$253K | 0.15% | 135 |
|
|
2021
Q3 | $16.9M | Sell |
336,680
-6,375
| -2% | -$319K | 0.17% | 136 |
|
|
2021
Q2 | $21.6M | Sell |
343,055
-197,565
| -37% | -$12.4M | 0.22% | 122 |
|
|
2021
Q1 | $50.2M | Sell |
540,620
-117,146
| -18% | -$10.9M | 0.54% | 67 |
|
|
2020
Q4 | $58.9M | Buy |
657,766
+388,709
| +144% | +$34.8M | 0.69% | 47 |
|
|
2020
Q3 | $27.8M | Buy |
269,057
+73,161
| +37% | +$7.56M | 0.39% | 90 |
|
|
2020
Q2 | $15.5M | Sell |
195,896
-64,059
| -25% | -$5.07M | 0.22% | 133 |
|
|
2020
Q1 | $15M | Sell |
259,955
-118,461
| -31% | -$6.85M | 0.26% | 120 |
|
|
2019
Q4 | $20.4M | Sell |
378,416
-299,212
| -44% | -$16.1M | 0.25% | 124 |
|
|
2019
Q3 | $35.4M | Buy |
677,628
+106,219
| +19% | +$5.55M | 0.47% | 83 |
|
|
2019
Q2 | $27.6M | Buy |
571,409
+44,009
| +8% | +$2.13M | 0.37% | 98 |
|
|
2019
Q1 | $26.6M | Buy |
+527,400
| New | +$26.6M | 0.36% | 108 |
|